This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bratu, S.
Right arrow Articles by Quale, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bratu, S.
Right arrow Articles by Quale, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 2005, p. 776-778, Vol. 49, No. 2
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.2.776-778.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Detection of KPC Carbapenem-Hydrolyzing Enzymes in Enterobacter spp. from Brooklyn, New York

Simona Bratu,1 David Landman,1 Maqsood Alam,1 Elaine Tolentino,2 and John Quale1*

Division of Infectious Diseases,1 Department of Microbiology, State University of New York—Downstate, Brooklyn, New York2

Received 17 May 2004/ Returned for modification 10 August 2004/ Accepted 3 October 2004


arrow
ABSTRACT
 
Enterobacter spp. are rarely resistant to carbapenems. In this report, one Enterobacter sp. isolate possessed blaKPC-3 and two possessed blaKPC-2. For all three strains, the imipenem MICs were dependent on the inoculum and testing method; two were reported by the clinical laboratories to be carbapenem susceptible. Improved detection methods will be necessary to identify these enzymes.


arrow
TEXT
 
Enterobacter spp. are the third most common pathogen causing pneumonia and the fifth most common pathogen causing bloodstream and surgical site infections in intensive care facilities in the United States (15). Although ~25% are resistant to expanded-spectrum cephalosporins, carbapenem-resistant Enterobacter spp. remain very unusual (3). Carbapenem resistance in E. aerogenes has been attributed to overproduction of chromosomal cephalosporinase and loss of porins (1, 4, 5, 16). E. cloacae rarely may acquire class A carbapenem-hydrolyzing ß-lactamases, such as NMC-A (9, 11) and IMI-1 (14). The carbapenem-hydrolyzing enzyme KPC-2 has been recovered in isolates of Klebsiella spp. (2, 7, 18) and in an isolate of E. cloacae (A. Hossain, M. J. Ferraro, R. M. Pino, R. B. Dew, E. S. Moland, T. J. Lockhart, K. S. Thomson, R. V. Goering, and N. D. Hanson, Abstr. 43rd Intersci. Conf. Antimicrob. Agents Chemother., abstr. C1-664, 2003). A related enzyme, KPC-3, has been recovered in isolates of K. pneumoniae (K. Young, P. Tierno, Jr., L. Tysall, M. F. Palepou, R. Painter, D. Suber, D. Shungu, L. Silver, K. Inglima, J. Kornblum, N. Woodford, and D. Livermore, Abstr. 43rd ICAAC, abstr. C2-50, 2003) and E. coli (T. Hong, E. S. Moland, B. Abdalhamid, N. D. Hanson, J. Wang, C. Sloan, D. Fabian, A. Farrajallah, J. Levine, and K. S. Thomson, Abstr. 43rd ICAAC, abstr. C1-665, 2003). In this report, we describe the finding of the ß-lactamase KPC-3 in a clinical isolate of E. cloacae. The finding of this ß-lactamase prompted a retrospective examination of the prevalence of KPC-possessing Enterobacter spp. in Brooklyn, N.Y.

A clinical isolate of carbapenem-resistant E. cloacae, M61782, was identified in October 2003. The prevalence of KPC ß-lactamases was estimated by testing clinical isolates of Enterobacter spp. collected during citywide surveillance studies conducted in 2001 and 2003 (13). Identification of KPC-possessing isolates was confirmed by the API 20E system (bioMerieux).

Antibiotics were either obtained from Sigma, Inc. (St. Louis, Mo.) or were gifts from the manufacturers. MICs were determined using the agar dilution method, and they were interpreted according to established methods (8). MICs of tigecycline were determined by the broth microdilution technique. The MICs for KPC-possessing isolates were also tested by the Etest method and the broth microdilution method in cation-supplemented Mueller-Hinton broth using a variety of inocula.

Isoelectric focusing was performed on a polyacrylamide gel (ampholytes [pH 3 to 10]) as previously described (12). ß-Lactamases were amplified using previously described primers and conditions (2, 10). Isolates collected during the citywide surveillance studies with a ceftazidime MIC of ≥32 µg/ml were chosen to be tested for the presence of KPC enzymes. Amplified products underwent bidirectional sequencing performed with the automated fluorescent dye terminator sequencing system (Applied Biosystems, Foster City, Calif.). The following additional internal primers were included for sequencing of blaKPC: 5'-AGCTGAACTCCGCCATCC-3' (forward) and 5'-CCGCCCAACTCCTTCAGC-3' (reverse).

In October 2003, E. cloacae M61782 was repeatedly isolated from a wound culture. The patient resided in a nursing home and had previously been at another hospital. The isolate was found by the clinical laboratory to be resistant to all tested antibiotics except amikacin. The patient was successfully treated with a regimen that included amikacin and gatifloxacin. Isoelectric focusing revealed ß-lactamases with pI values of 5.4, 6.7, and >9. Sequencing results confirmed the presence of blaKPC-3 and blaTEM-1.

A total of 351 single-patient Enterobacter spp. isolates were collected in the citywide surveillances conducted in 2001 and 2003, including 120 E. aerogenes, 216 E. cloacae, and 15 other Enterobacter spp. isolates. Susceptibility results are reported in Table 1. A total of 111 ceftazidime-resistant isolates were screened for KPC ß-lactamase. All but 1 of the 111 isolates were found to be susceptible to carbapenems according to agar dilution methodology. Two of the 111 isolates were found to harbor KPC enzymes, including an E. cloacae isolate (DM303) in 2001 and an E. aerogenes isolate (MA504) in 2003. Ribotyping revealed that the E. cloacae isolate DM303 was unrelated to M61782 (data not shown). Both isolates possessed a ß-lactamase with a pI of 6.7, identified by nucleotide sequencing as blaKPC-2. The isolate of E. cloacae originated from a patient with renal failure and continuous bacteremia spanning 20 days. Five of the six blood cultures growing E. cloacae were reported by the clinical microbiology laboratory as susceptible to imipenem; the sixth was considered intermediate (using the Dade Microscan WalkAway System; Dade International, Inc., West Sacramento, Calif.). The patient was successfully treated with aminoglycoside therapy and catheter removal. The E. aerogenes MA504 isolate, cultured from the sputum of a patient with necrotizing pneumonia, was reported as susceptible to carbapenems by the clinical microbiology laboratory by using the Vitek System (bioMerieux Vitek, Hazelwood, Mo.). The patient was treated with a regimen that included imipenem, but the patient expired after 1 week of therapy.


View this table:
[in this window]
[in a new window]
  		TABLE 1. Susceptibility results of Enterobacter aerogenes and E. cloacae gathered during citywide surveillances in 2001 and 2003

The imipenem MICs for M61782, DM303, and MA504 were tested using a variety of methods (Table 2). The interpretation of the susceptibility of these strains differed considerably depending on the method and inoculum used. For the broth microdilution method, the imipenem MIC increased considerably as the amount of inoculum increased.


View this table:
[in this window]
[in a new window]
  		TABLE 2. MICs of carbapenems (in micrograms/milliliter) for three KPC-possessing strains of Enterobacter spp.

Carbapenems are an important component of antimicrobial regimens for nosocomial infections. Carbapenem resistance in E. aerogenes (1, 4, 5, 16) is rarely reported; this is the first report of a carbapenemase in E. aerogenes and of blaKPC-3 in E. cloacae.

The emergence of KPC-type carbapenem-hydrolyzing enzymes in the northeastern United States is alarming. They may reside on transmissible plasmids (6, 17, 18) and have been found in different genera (2, 6, 7, 18). Our retrospective search for Enterobacter-possessing KPC ß-lactamases suggests that clinical laboratories may not be accurately identifying these isolates. Although our data are limited to only three isolates, two were reported to be susceptible to carbapenems by using automated systems. Compared to the results obtained using the Etest method, the imipenem MICs were considerably lower using agar and broth dilution with standard inocula. Because isolates carrying KPC enzymes are frequently resistant to other classes of antibiotics (2), treatment strategies are severely hampered. Only a concerted effort involving improved detection and infection control will prevent the continued spread of these resistant pathogens.

Nucleotide sequence accession number. The nucleotide sequence of the blaKPC-3 gene from E. cloacae M61782 has been included in the GenBank database as accession number AY522950.


arrow
ACKNOWLEDGMENTS
 
This work was supported by grants from Merck & Co., Inc.; Pfizer, Inc.; Wyeth-Ayerst Pharmaceuticals; and Elan Pharmaceuticals.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: SUNY Downstate, Box 77, Division of Infectious Diseases, 450 Clarkson Ave., Brooklyn, NY 11203. Phone: (718) 270-2148. Fax: (718) 270-2465. E-mail: jquale{at}downstate.edu. Back


arrow
REFERENCES
 
    1
  1. Bornet, C., A. Davin-Regli, C. Bosi, J. M. Pages, and C. Bollet. 2000. Imipenem resistance of Enterobacter aerogenes mediated by outer membrane permeability. J. Clin. Microbiol. 38:1048-1052.[Abstract/Free Full Text]
    2. 2
  2. Bradford, P. A., S. Bratu, C. Urban, M. Visalli, N. Mariano, D. Landman, J. J. Rahal, S. Brooks, et al. 2003. Emergence of carbapenem-resistant Klebsiella spp. possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 ß-lactamases in New York City. Clin. Infect. Dis. 39:55-60.
    3. 3
  3. Centers for Disease Control and Prevention. 2002. National nosocomial infections surveillance system report, data summary from January 1992 to June 2002. Am. J. Infect. Control 30:458-475.[CrossRef][Medline]
    4. 4
  4. Chow, J. W., and D. M. Shlaes. 1991. Imipenem resistance associated with the loss of a 40 kDa outer membrane protein in Enterobacter aerogenes. J. Antimicrob. Chemother. 28:499-504.[Abstract/Free Full Text]
    5. 5
  5. de Champes, C., C. Henquell, D. Guelon, D. Sirot, N. Gazuy, and J. Sirot. 1993. Clinical and bacteriological study of nosocomial infections due to Enterobacter aerogenes resistant to imipenem. J. Clin. Microbiol. 31:123-127.[Abstract/Free Full Text]
    6. 6
  6. Miriagou, V., L. S. Tzouvelekis, S. Rossiter, E. Tzelepi, F. J. Angulo, and J. M. Whichard. 2003. Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob. Agents Chemother. 47:1297-1300.[Abstract/Free Full Text]
    7. 7
  7. Moland, E. S., N. D. Hanson, V. L. Herrera, J. A. Black, T. J. Lockhart, A. Hossain, J. A. Johnson, R. V. Goering, and K. S. Thomson. 2003. Plasmid-mediated, carbapenem-hydrolysing ß-lactamase, KPC-2, in Klebsiella pneumoniae isolates. J. Antimicrob. Chemother. 51:711-714.[Abstract/Free Full Text]
    8. 8
  8. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacterial that grow aerobically. Approved standard M7-A5, 5th ed. National Committee for Clinical Laboratory Standards, Wayne, Pa.
    9. 9
  9. Nordmann, P., S. Mariotte, T. Naas, R. Labia, and M. H. Nicolas. 1993. Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Antimicrob. Agents Chemother. 37:939-946.[Abstract/Free Full Text]
    10. 10
  10. Paterson, D. L., K. M. Hujer, A. M. Hujer, B. Yeiser, M. D. Bonomo, L. B. Rice, R. A. Bonomo and the International Klebsiella Study Group. 2003. Extended-spectrum ß-lactamase in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type ß-lactamases. Antimicrob. Agents Chemother. 47:3554-3560.[Abstract/Free Full Text]
    11. 11
  11. Pottumarthy, S., E. S. Moland, S. Juretschko, S. R. Swanzy, K. S. Thomson, and T. R. Fritsche. 2003. NmcA carbapenem-hydrolyzing enzyme in Enterobacter cloacae in North America. Emerg. Infect. Dis. 9:999-1002.[Medline]
    12. 12
  12. Quale, J., S. Bratu, D. Landman, and R. Heddurshetti. 2003. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin. Infect. Dis. 37:214-220.[CrossRef][Medline]
    13. 13
  13. Quale, J. M., D. Landman, P. A. Bradford, M. Visalli, J. Ravishankar, C. Flores, D. Mayorga, K. Vangala, and A. Adedeji. 2002. Molecular epidemiology of a citywide outbreak of extended-spectrum ß-lactamase-producing Klebsiella pneumoniae infection. Clin. Infect. Dis. 35:834-841.[CrossRef][Medline]
    14. 14
  14. Rasmussen, B. A., K. Bush, D. Keeney, Y. Yang, R. Hare, C. O'Gara, and A. A. Medeiros. 1996. Characterization of IMI-1 ß-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrob. Agents Chemother. 40:2080-2086.[Abstract]
    15. 15
  15. Weber, D. J., R. Raasch, and W. A. Rutala. 1999. Nosocomial infections in the ICU. The growing importance of antibiotic-resistant pathogens. Chest 115:34S-41S.
    16. 16
  16. Yigit, H., G. J. Anderson, J. W. Biddle, C. D. Steward, J. K. Rasheed, L. L. Valera, J. E. McGowan, Jr., and F. C. Tenover. 2002. Carbapenem resistance in a clinical isolate of Enterobacter aerogenes is associated with decreased expression of OmpF and OmpC porin analogs. Antimicrob. Agents Chemother. 46:3817-3822.[Abstract/Free Full Text]
    17. 17
  17. Yigit, H., A. M. Queenan, G. J. Anderson, A. Domenech-Sanchez, J. W. Biddle, C. D. Steward, S. Alberti, K. Bush, and F. C. Tenover. 2001. Novel carbapenem-hydrolzying ß-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45:1151-1161.[Abstract/Free Full Text]
    18. 18
  18. Yigit, H., A. M. Queenan, J. K. Rasheed, J. W. Biddle, A. Domenech-Sanchez, S. Alberti, K. Bush, and F. C. Tenover. 2003. Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing ß-lactamase KPC-2. Antimicrob. Agents Chemother. 47:3881-3889.[Abstract/Free Full Text]

Antimicrobial Agents and Chemotherapy, February 2005, p. 776-778, Vol. 49, No. 2
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.2.776-778.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Kitchel, B., Rasheed, J. K., Patel, J. B., Srinivasan, A., Navon-Venezia, S., Carmeli, Y., Brolund, A., Giske, C. G. (2009). Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258. Antimicrob. Agents Chemother. 53: 3365-3370 [Abstract] [Full Text]  
  • Wolter, D. J., Khalaf, N., Robledo, I. E., Vazquez, G. J., Sante, M. I., Aquino, E. E., Goering, R. V., Hanson, N. D. (2009). Surveillance of Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Puerto Rican Medical Center Hospitals: Dissemination of KPC and IMP-18 {beta}-Lactamases. Antimicrob. Agents Chemother. 53: 1660-1664 [Abstract] [Full Text]  
  • Petrella, S., Ziental-Gelus, N., Mayer, C., Renard, M., Jarlier, V., Sougakoff, W. (2008). Genetic and Structural Insights into the Dissemination Potential of the Extremely Broad-Spectrum Class A {beta}-Lactamase KPC-2 Identified in an Escherichia coli Strain and an Enterobacter cloacae Strain Isolated from the Same Patient in France. Antimicrob. Agents Chemother. 52: 3725-3736 [Abstract] [Full Text]  
  • Hindiyeh, M., Smollen, G., Grossman, Z., Ram, D., Davidson, Y., Mileguir, F., Vax, M., Ben David, D., Tal, I., Rahav, G., Shamiss, A., Mendelson, E., Keller, N. (2008). Rapid Detection of blaKPC Carbapenemase Genes by Real-Time PCR. J. Clin. Microbiol. 46: 2879-2883 [Abstract] [Full Text]  
  • Tibbetts, R., Frye, J. G., Marschall, J., Warren, D., Dunne, W. (2008). Detection of KPC-2 in a Clinical Isolate of Proteus mirabilis and First Reported Description of Carbapenemase Resistance Caused by a KPC {beta}-Lactamase in P. mirabilis. J. Clin. Microbiol. 46: 3080-3083 [Abstract] [Full Text]  
  • Cai, J. C., Zhou, H. W., Zhang, R., Chen, G.-X. (2008). Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates Possessing the Plasmid-Mediated Carbapenem-Hydrolyzing {beta}-Lactamase KPC-2 in Intensive Care Units of a Chinese Hospital. Antimicrob. Agents Chemother. 52: 2014-2018 [Abstract] [Full Text]  
  • Rasheed, J. K., Biddle, J. W., Anderson, K. F., Washer, L., Chenoweth, C., Perrin, J., Newton, D. W., Patel, J. B. (2008). Detection of the Klebsiella pneumoniae Carbapenemase Type 2 Carbapenem-Hydrolyzing Enzyme in Clinical Isolates of Citrobacter freundii and K. oxytoca Carrying a Common Plasmid. J. Clin. Microbiol. 46: 2066-2069 [Abstract] [Full Text]  
  • Zhang, R., Yang, L., Cai, J. C., Zhou, H. W., Chen, G.-X. (2008). High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression. J Med Microbiol 57: 332-337 [Abstract] [Full Text]  
  • Walther-Rasmussen, J., Hoiby, N. (2007). Class A carbapenemases. J Antimicrob Chemother 60: 470-482 [Abstract] [Full Text]  
  • Anderson, K. F., Lonsway, D. R., Rasheed, J. K., Biddle, J., Jensen, B., McDougal, L. K., Carey, R. B., Thompson, A., Stocker, S., Limbago, B., Patel, J. B. (2007). Evaluation of Methods To Identify the Klebsiella pneumoniae Carbapenemase in Enterobacteriaceae. J. Clin. Microbiol. 45: 2723-2725 [Abstract] [Full Text]  
  • Thomson, K. S., Cornish, N. E., Hong, S. G., Hemrick, K., Herdt, C., Moland, E. S. (2007). Comparison of Phoenix and VITEK 2 Extended-Spectrum-{beta}-Lactamase Detection Tests for Analysis of Escherichia coli and Klebsiella Isolates with Well-Characterized {beta}-Lactamases. J. Clin. Microbiol. 45: 2380-2384 [Abstract] [Full Text]  
  • Queenan, A. M., Bush, K. (2007). Carbapenemases: the Versatile {beta}-Lactamases. Clin. Microbiol. Rev. 20: 440-458 [Abstract] [Full Text]  
  • Villegas, M. V., Lolans, K., Correa, A., Kattan, J. N., Lopez, J. A., Quinn, J. P., and the Colombian Nosocomial Resistance Study Grou, (2007). First Identification of Pseudomonas aeruginosa Isolates Producing a KPC-Type Carbapenem-Hydrolyzing {beta}-Lactamase. Antimicrob. Agents Chemother. 51: 1553-1555 [Abstract] [Full Text]  
  • Zhang, R., Zhou, H. W., Cai, J. C., Chen, G.-X. (2007). Plasmid-mediated carbapenem-hydrolysing {beta}-lactamase KPC-2 in carbapenem-resistant Serratia marcescens isolates from Hangzhou, China. J Antimicrob Chemother 59: 574-576 [Full Text]  
  • Navon-Venezia, S., Chmelnitsky, I., Leavitt, A., Schwaber, M. J., Schwartz, D., Carmeli, Y. (2006). Plasmid-Mediated Imipenem-Hydrolyzing Enzyme KPC-2 among Multiple Carbapenem-Resistant Escherichia coli Clones in Israel.. Antimicrob. Agents Chemother. 50: 3098-3101 [Abstract] [Full Text]  
  • Moland, E. S., Hanson, N. D., Black, J. A., Hossain, A., Song, W., Thomson, K. S. (2006). Prevalence of Newer {beta}-Lactamases in Gram-Negative Clinical Isolates Collected in the United States from 2001 to 2002.. J. Clin. Microbiol. 44: 3318-3324 [Abstract] [Full Text]  
  • Virginia Villegas, M., Lolans, K., Correa, A., Jose Suarez, C., Lopez, J. A., Vallejo, M., Quinn, J. P., the Colombian Nosocomial Resistance Study Group, (2006). First Detection of the Plasmid-Mediated Class A Carbapenemase KPC-2 in Clinical Isolates of Klebsiella pneumoniae from South America.. Antimicrob. Agents Chemother. 50: 2880-2882 [Abstract] [Full Text]  
  • Alba, J., Ishii, Y., Thomson, K., Moland, E. S., Yamaguchi, K. (2005). Kinetics Study of KPC-3, a Plasmid-Encoded Class A Carbapenem-Hydrolyzing {beta}-Lactamase. Antimicrob. Agents Chemother. 49: 4760-4762 [Abstract] [Full Text]  
  • Landman, D., Salvani, J. K., Bratu, S., Quale, J. (2005). Evaluation of Techniques for Detection of Carbapenem-Resistant Klebsiella pneumoniae in Stool Surveillance Cultures. J. Clin. Microbiol. 43: 5639-5641 [Abstract] [Full Text]  
  • Bratu, S., Mooty, M., Nichani, S., Landman, D., Gullans, C., Pettinato, B., Karumudi, U., Tolaney, P., Quale, J. (2005). Emergence of KPC-Possessing Klebsiella pneumoniae in Brooklyn, New York: Epidemiology and Recommendations for Detection. Antimicrob. Agents Chemother. 49: 3018-3020 [Abstract] [Full Text]  
  • Bratu, S., Tolaney, P., Karumudi, U., Quale, J., Mooty, M., Nichani, S., Landman, D. (2005). Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. J Antimicrob Chemother 56: 128-132 [Abstract] [Full Text]  
  • Bratu, S., Landman, D., Haag, R., Recco, R., Eramo, A., Alam, M., Quale, J. (2005). Rapid Spread of Carbapenem-Resistant Klebsiella pneumoniae in New York City: A New Threat to Our Antibiotic Armamentarium. Arch Intern Med 165: 1430-1435 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bratu, S.
Right arrow Articles by Quale, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bratu, S.
Right arrow Articles by Quale, J.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»